- Home
- VYGR vs ECBK Comparison
VYGR vs ECBK Comparison
Compare VYGR & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- ECBK
- Stock Information
- Founded
- VYGR 2013
- ECBK 1919
- Country
- VYGR United States
- ECBK United States
- Employees
- VYGR N/A
- ECBK N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- ECBK Banks
- Sector
- VYGR Health Care
- ECBK Finance
- Exchange
- VYGR Nasdaq
- ECBK Nasdaq
- Market Cap
- VYGR 164.3M
- ECBK 151.0M
- IPO Year
- VYGR 2015
- ECBK N/A
- Fundamental
- Price
- VYGR $3.20
- ECBK $16.01
- Analyst Decision
- VYGR Strong Buy
- ECBK
- Analyst Count
- VYGR 8
- ECBK 0
- Target Price
- VYGR $14.33
- ECBK N/A
- AVG Volume (30 Days)
- VYGR 715.4K
- ECBK 66.9K
- Earning Date
- VYGR 08-05-2025
- ECBK 08-08-2025
- Dividend Yield
- VYGR N/A
- ECBK N/A
- EPS Growth
- VYGR N/A
- ECBK 17.87
- EPS
- VYGR N/A
- ECBK 0.57
- Revenue
- VYGR $66,958,000.00
- ECBK $26,906,000.00
- Revenue This Year
- VYGR N/A
- ECBK N/A
- Revenue Next Year
- VYGR $78.88
- ECBK N/A
- P/E Ratio
- VYGR N/A
- ECBK $28.25
- Revenue Growth
- VYGR N/A
- ECBK 5.99
- 52 Week Low
- VYGR $2.65
- ECBK $12.48
- 52 Week High
- VYGR $9.55
- ECBK $16.99
- Technical
- Relative Strength Index (RSI)
- VYGR 51.88
- ECBK 60.11
- Support Level
- VYGR $2.83
- ECBK $14.82
- Resistance Level
- VYGR $3.43
- ECBK $15.51
- Average True Range (ATR)
- VYGR 0.19
- ECBK 0.39
- MACD
- VYGR 0.01
- ECBK 0.12
- Stochastic Oscillator
- VYGR 55.22
- ECBK 98.35
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.